https://www.selleckchem.com/pr....oducts/CI-1040-(PD18
Although many VA treatments are used, there is little information on their efficacy. Most patients do not achieve complete control. The novel VA classification proposed could help clinicians with the diagnostic workup of patients with VA. Because of the paucity of reported cases, firm recommendations for the treatment of VA are currently not possible. For patients with acquired VA, we suggest second-generation H -antihistamines as the first-line treatment. Controlled therapeutic trials are needed and should be performed. The
Like
Comment
Share
